AquAdvantage announced FDA approval of first U.S. facility for commercial production of AquAdvantage Salmon
On Apr. 27, 2018, AquaBounty Technologies announced that it had received approval from the U.S. Food and Drug…
On Apr. 27, 2018, AquaBounty Technologies announced that it had received approval from the U.S. Food and Drug…
On Mar. 20, 2018, in response to the Ebola outbreak that claimed more than 10,000 lives in West…
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
On Mar. 2, 2017, scientists discovered the oldest evidence of life on Earth in fossilized microorganisms that are…
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
On Oct, 26, 2016, a team of researchers at the University of Arizona and University of Cambridge in…
On Oct. 3, 2016, Okanagan Specialty Fruits (OSF) announced that it had successfully completed the first commercial harvest…
On May 20, 2016, AquaBounty Technologies announced that Health Canada had concluded its review of the AquAdvantage Salmon…
On Sept. 5, 2017, business incubator TEC Edmonton announced a strategic partnership with Merck Canada to provide new…
On Nov. 19, 2015, AquaBounty Technologies announced the U.S. Food and Drug Administration (FDA) had approved the Company’s…
On Apr. 23, 2015, an international collaboration that involved researchers from Sweden, the United States, Canada, and Russia…
On Feb. 28, 2014, the Djavad Mowafaghian Centre for Brain Health (DMCBH), a partnership between the University of…
On Mar. 27, 2013, researchers at the University of British Columbia and Canada’s Michael Smith Genome Sciences Centre…
On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…
On Jan. 12, 2011, The Danforth Foundation’s made a final gift of $70 million to the Donald Danforth…
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
In 2009, Dr. Andras Nagy reported the discovery of a new non-viral method of creating stem cells from…
On May 22, 2008, the New Mexico Dept. of Health notified the U.S. Centers for Disease Control and…
On Sept. 28, 2007, the National Institute for Nanotechnology’s (NINT) Innovation Centre at the University of Alberta officially…
On Feb. 24, 2006, the Advisory Committee on Immunization Practices (ACIP) was informed by the only U.S.-licensed manufacturer…
On Jun 8, 2005, Dr. Andras Nagy at Mount Sinai Hospital announced Canada’s first human embryonic stem cell…
In 2005, Genome Alberta, was established in partnership with Genome Canada Industry Canada and the Province of Alberta,…
In 2005, the National Institute for Nanotechnology (NINT) was founded as a joint initiative between the Government of…
In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…
On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
On Jul. 24, 2001, the largest-ever prostate cancer prevention study was launched by the National Cancer Institute and…
On Apr. 24, 2001, Genome Canada announced $136 million in funding to support 22 large-scale research projects and…